Surrogate End Points in Soft Tissue Sarcoma: Methodologic Challenges Reply

被引：0
作者：
Zhao, Fengmin [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 32期
关键词：
PROGRESSION-FREE SURVIVAL; METASTATIC BREAST-CANCER; CLINICAL-TRIALS; TIME;
D O I：
10.1200/JCO.2016.69.1063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3951 / +
页数：2
相关论文
共 10 条
  • [1] [Anonymous], BIOSTATISTICS
  • [2] Validation of surrogate end points in multiple randomized clinical trials with failure time end points
    Burzykowski, T
    Molenberghs, G
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2001, 50 : 405 - 422
  • [3] Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer
    Burzykowski, Tomasz
    Buyse, Marc
    Piccart-Gebhart, Martine J.
    Sledge, George
    Carmichael, James
    Lueck, Hans-Joachim
    Mackey, John R.
    Nabholtz, Jean-Marc
    Paridaens, Robert
    Biganzoli, Laura
    Jassem, Jacek
    Bontenbal, Marijke
    Bonneterre, Jacques
    Chan, Stephen
    Basaran, Gul Atalay
    Therasse, Patrick
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 1987 - 1992
  • [4] Progression-free survival is a surrogate for survival in advanced colorectal cancer
    Buyse, Marc
    Burzykowski, Tomasz
    Carroll, Kevin
    Michiels, Stefan
    Sargent, Daniel J.
    Miller, Langdon L.
    Elfring, Gary L.
    Pignon, Jean-Pierre
    Piedbois, Pascal
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5218 - 5224
  • [5] Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
    Cortazar, Patricia
    Zhang, Lijun
    Untch, Michael
    Mehta, Keyur
    Costantino, Joseph P.
    Wolmark, Norman
    Bonnefoi, Herve
    Cameron, David
    Gianni, Luca
    Valagussa, Pinuccia
    Swain, Sandra M.
    Prowell, Tatiana
    Loibl, Sibylle
    Wickerham, D. Lawrence
    Bogaerts, Jan
    Baselga, Jose
    Perou, Charles
    Blumenthal, Gideon
    Blohmer, Jens
    Mamounas, Eleftherios P.
    Bergh, Jonas
    Semiglazov, Vladimir
    Justice, Robert
    Eidtmann, Holger
    Paik, Soonmyung
    Piccart, Martine
    Sridhara, Rajeshwari
    Fasching, Peter A.
    Slaets, Leen
    Tang, Shenghui
    Gerber, Bernd
    Geyer, Charles E., Jr.
    Pazdur, Richard
    Ditsch, Nina
    Rastogi, Priya
    Eiermann, Wolfgang
    von Minckwitz, Gunter
    [J]. LANCET, 2014, 384 (9938) : 164 - 172
  • [6] Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data
    Mauguen, Audrey
    Pignon, Jean-Pierre
    Burdett, Sarah
    Domerg, Caroline
    Fisher, David
    Paulus, Rebecca
    Mandrekar, Samithra J.
    Belani, Chandra P.
    Shepherd, Frances A.
    Eisen, Tim
    Pang, Herbert
    Collette, Laurence
    Sause, William T.
    Dahlberg, Suzanne E.
    Crawford, Jeffrey
    O'Brien, Mary
    Schild, Steven E.
    Parmar, Mahesh
    Tierney, Jayne F.
    Le Pechoux, Cecile
    Michiels, Stefan
    [J]. LANCET ONCOLOGY, 2013, 14 (07) : 619 - 626
  • [7] Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer
    Michiels, S.
    Pugliano, L.
    Marguet, S.
    Grun, D.
    Barinoff, J.
    Cameron, D.
    Cobleigh, M.
    Di Leo, A.
    Johnston, S.
    Gasparini, G.
    Kaufman, B.
    Marty, M.
    Nekljudova, V.
    Paluch-Shimon, S.
    Penault-Llorca, F.
    Slamon, D.
    Vogel, C.
    von Minckwitz, G.
    Buyse, M.
    Piccart, M.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (06) : 1029 - 1034
  • [8] Surrogate End Points in Soft Tissue Sarcoma: Methodologic Challenges
    Renfro, Lindsay A.
    Shi, Qian
    Sargent, Daniel J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3949 - +
  • [9] Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials
    Shi, Qian
    Renfro, Lindsay A.
    Bot, Brian M.
    Burzykowski, Tomasz
    Buyse, Marc
    Sargent, Daniel J.
    [J]. COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2011, 55 (09) : 2748 - 2757
  • [10] Evolution of Randomized Trials in Advanced/Metastatic Soft Tissue Sarcoma: End Point Selection, Surrogacy, and Quality of Reporting
    Zer, Alona
    Prince, Rebecca M.
    Amir, Eitan
    Razak, Albiruni Abdul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (13) : 1469 - +
1